[Colonic ulcer after prolongated administration of Kayexalate (sodium polystyrene sulfonate)].
Hourseau
Muriel
M
Lagorce-Pages
Christine
C
Benamouzig
Robert
R
Tuil
Olivier
O
Ecomard
Marie-Adèle
MA
Zemoura
Leila
L
Martin
Antoine
A
D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003108:Colonic Diseases / Q000139:chemically induced*; D004334:Drug Administration Schedule; D006801:Humans; D007676:Kidney Failure, Chronic; D008297:Male; D008875:Middle Aged; D011137:Polystyrenes / Q000009:adverse effects* / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D016868:Serratia Infections / Q000188:drug therapy; D012706:Serratia marcescens / Q000472:pathogenicity; D014456:Ulcer / Q000139:chemically induced*
D000890:Anti-Infective Agents; D011137:Polystyrenes; C003321:polystyrene sulfonic acid